UCB stock holds firm as August 2026 update nears
Published on 08/25/2026 at 16:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UCB stock, tied to ISIN BE0003739530, remains a Belgium-listed healthcare name with a recent market value of EUR 41.946 billion and a quote around EUR 220.00 as reflected in same-day market data.
That market backdrop matters because the same data point shows a daily move of -0.77% and places the shares against a 52-week range that has already been marked in the August 2026 quote set.
Half-year numbers still set the tone
The latest reported operating picture visible in the recent market feed points to a first-half 2026 revenue figure of EUR 2.55 billion and earnings per share of EUR 4.44, both attached to the half-year reporting period ending June 30, 2026.
Those figures give the stock a concrete reference point: revenue and EPS are both current enough for the August 25, 2026 frame, and the comparison with the prior-year half is straightforward because the same feed shows the half-year report as the benchmark period.
What the market is pricing
Consensus data in the same snapshot indicates an average target price of EUR 240.00 and a moderate buy stance, which leaves the shares trading below that level by 20.00 EUR on the quoted price used for this update.
The contrast is simple. A EUR 220.00 share price against a EUR 240.00 consensus target leaves a 9.1% gap, while the EUR 41.946 billion market value keeps UCB in the upper tier of European biotech valuations.
Representative product
Bimzelx remains one of UCB's best-known products and is central to how investors frame the company's commercial base.
UCB stock and the price setup
UCB stock trades on Euronext Brussels in euro terms, with the most recent market snapshot showing EUR 220.00 and a -0.77% session move as of August 24, 2026. The same session context leaves the shares a meaningful distance from the EUR 240.00 average target in the consensus data.
Company
Company: UCB SA/NV
ISIN: BE0003739530
Ticker: UCB
Exchange: Euronext Brussels
Price (as of August 24, 2026): EUR 220.00
Market cap: EUR 41.946 billion
Sector / Industry: Healthcare / Biotechnology
Index membership: BEL 20
